Science Explorer Back to mapMap
Discussion
Researcher · University of Helsinki · Finland

Ari Rouhiainen

Ari Rouhiainen publishes mostly in Clinical Biochemistry, Immunology and Molecular Biology, on topics such as Advanced Glycation End Products research, Immune Response and Inflammation and S100 Proteins and Annexins.

ORCID 0000-0003-2492-4788 OpenAlex
World rank
#1,126,425
of 7,710,434 ranked researchers
Rank in Finland
#6,837
of 37,370
Works
24
Citations
2.2k
Citations per work
93.3
h-index
18
i10-index 20Top 27% in Clinical Biochemistry
Ari Rouhiainen

What does Ari Rouhiainen research?

Ari Rouhiainen's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Immunology and Microbiology (22%), Medicine (11%).

Life Sciences: 16 works · 64.7% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 36.6% of their workClinical Biochemistry: 6 works · 23.9% of their workMolecular Biology: 3 works · 12.7% of their workImmunology and Microbiology: 5 works · 22.5% of their workImmunology: 5 works · 22.5% of their workNeuroscience: 1 works · 5.6% of their workCellular and Molecular Neuroscience: 1 works · 5.6% of their workEverything else: 6 works · 24.1% of their workHealth Sciences: 3 works · 11.2% of their workMedicine: 3 works · 11.2% of their workEpidemiology: 1 works · 5.6% of their workSurgery: 1 works · 5.6% of their workTHEIR WORKAri Rouhiainen24works
Life Sciences65%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology936.6%
    2. Immunology and Microbiology522.5%
    3. Neuroscience15.6%
  2. Everything else624.1%
    1. Medicine311.2%
  1. 1Clinical Biochemistry24% of their works
  2. 2Immunology22% of their works
  3. 3Molecular Biology13% of their works
  4. 4Cellular and Molecular Neuroscience6% of their works
  5. 5Epidemiology6% of their works
  6. 6Surgery6% of their works

Research topics

Which keywords describe Ari Rouhiainen's research?

The keywords of their largest research topics: Inflammation, Toll-like Receptors, Advanced Glycation End Products, HMGB1, Innate Immunity, Innate Antiviral Responses, Pattern Recognition Receptors and Calcium Modulated Proteins.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Inflammation325 topics
  2. Toll-like Receptors232 topics
  3. Advanced Glycation End Products171 topic
  4. HMGB1171 topic
  5. Innate Immunity82 topics
  6. Innate Antiviral Responses61 topic
  7. Pattern Recognition Receptors61 topic
  8. Calcium Modulated Proteins51 topic
  9. Epidemiology52 topics
  10. Immunity52 topics
  11. S100 Proteins51 topic
  12. Acute Pancreatitis31 topic
  13. Cancer Immunotherapy31 topic
  14. Chronic Pancreatitis31 topic
  15. Dendritic Cells31 topic
  16. Activation21 topic
  17. Adenosine Receptors21 topic
  18. Genetics21 topic
  19. Macrophage21 topic
  20. Purinergic Signalling21 topic
  21. Type 1 Diabetes21 topic

Where does Ari Rouhiainen work?

Ari Rouhiainen's main affiliation in the publication record is University of Helsinki, Finland.

How many publications and citations does Ari Rouhiainen have?

OpenAlex counts 24 works and 2,240 citations for Ari Rouhiainen, an h-index of 18, ranking #1,126,425 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ari Rouhiainen. Posts are plain text and can be reported.